Bayer

News

Sebastian Guth is promoted to chief operating officer, while Christine Roth will head new global commmercialisation unit

Guth named COO as Bayer revamps top pharma team

Bayer chief executive Bill Anderson has followed through on a pledge to streamline the group’s management, starting at the very top with a big reduction in the pharma unit

News

Bayer cues up filings for rival to Astellas’ menopause drug

Armed with new phase 3 data, Bayer has started preparing filings for elinzanetant as a treatment for vasomotor symptoms (VMS) associated with menopause, setting up a chall

News

Bayer CEO pulls back from breakup of ‘badly broken’ group

Bayer chief executive Bill Anderson pulled no punches in his assessment of the company at its annual results update, saying it is “badly broken” by patent losses, litigati

News

Bayer pays $310m for Euro rights to ATTR therapy acoramidis

Bayer has shored up its near-term pipeline by acquiring European rights to acoramidis from BridgeBio and Eidos Therapeutics, putting some big pharma muscle behind the ther

News

Bayer takes novel deep vein thrombosis drug into phase 2

Bayer has started proof-of-concept testing of a potential new therapy for patients with deep vein thrombosis (DVT) that works in a different way to current drugs.

R&D